Rahaf Ajaj: The Persistent Gender Gap in Nobel Prizes – A Call for Greater Inclusion
Rahaf Ajaj, Associate Professor at Abu Dhabi University, shared on LinkedIn:
”The Persistent Gender Gap in Nobel Prizes: A Call for Greater Inclusion
As the 2025 Nobel Prize announcements wrap up (with the Economic Sciences prize forthcoming), it’s a timely moment to reflect on the historical gender disparity in these esteemed awards.
While we celebrate the groundbreaking achievements of this year’s laureates, the data reveals a stark imbalance that underscores the need for continued efforts toward equity in academia, science, and global leadership.
From 1901 to 2025, only 67 women have received Nobel Prizes across all categories.
In comparison, men have dominated, with over 900 male laureates during the same period—highlighting a ratio where women represent less than 7% of individual winners.
Breaking it down by category (updated from the attached Statista infographic, which covers up to 2023):
• Peace: 20 women (including María Corina Machado in 2025 for her advocacy in Venezuela) 21 vs. approximately 92 men, plus 30 organizations.
• Literature: 18 women (including Han Kang in 2024 for her poignant prose) 21 vs. 103 men.
• Medicine/Physiology: 14 women (including Mary E. Brunkow in 2025 for discoveries in immune tolerance) 21 vs. around 186 men.
• Chemistry: 8 women vs. about 186 men.
• Physics: 5 women vs. roughly 220 men.
• Economics: 3 women vs. 90 men.
This distribution shows modest progress in recent years—2023 saw four female winners, 2024 one, and 2025 two so far—but the gap is particularly pronounced in STEM fields like Physics, Chemistry, and Economics, where systemic barriers, underrepresentation in research pipelines, and nomination biases continue to play a role.
As professionals in our respective fields, we must champion initiatives that amplify women’s contributions, from mentorship programs to equitable funding and recognition.
Closing this gap isn’t just about fairness; it’s about harnessing the full spectrum of human talent to drive innovation and societal progress.
What steps do you think organizations and institutions
should take to address this?
I’d love to hear your insights in the comments.”

Stay updated with Hemostasis Today.
-
Aug 29, 2026, 11:03Richard Davis: Navigating Acute PE – ESC vs. the New AHA/ACC Guidelines
-
Aug 29, 2026, 10:57Bartosz Hudzik: First RCT Evidence for a Long-Standing Guideline Gray Zone
-
Aug 29, 2026, 10:50Edward Lee Carter: Breakthrough Stroke Beyond ‘DOAC Failure’ – Risk Stratification Insights from ASPERA-R
-
Aug 29, 2026, 10:45Amir Askarinejad: SINGLE-AF at ESC 2026 – Important New Data for Anticoagulation in Intermediate-Risk AF
-
Aug 29, 2026, 10:26Paulus Kirchhof: Anticoagulation in Patients with a Single CHADS-VA Risk Factor
-
Aug 29, 2026, 10:22Syed Zohad Shah: Reducing Blood Loss and Hospital Stays in Non-Cardiac Thoracic Surgery
-
Aug 29, 2026, 10:13Eric Alderman: A New FDA-Approved Treatment for Warm Autoimmune Hemolytic Anemia
-
Aug 29, 2026, 09:10Ageing with a Bleeding Disorder Podcast – European Haemophilia Consortium
-
Aug 29, 2026, 09:04Abdul Muqtadir Abbasi: Perioperative Anticoagulation Management Chart